Cargando…
Relationship between diabetic polyneuropathy, serum visfatin, and oxidative stress biomarkers
BACKGROUND: Diabetic polyneuropathy is a very common complication of diabetes. Numerous studies are available in terms of pathogenesis. But examination methods with low reliability are still not standardized and generally time consuming. High-sensitive, easy-to-access methods are expected. Biochemic...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415233/ https://www.ncbi.nlm.nih.gov/pubmed/32843933 http://dx.doi.org/10.4239/wjd.v11.i7.309 |
_version_ | 1783569129596256256 |
---|---|
author | Buyukaydin, Banu Guler, Eray Metin Karaaslan, Tahsin Olgac, Atilla Zorlu, Mehmet Kiskac, Muharrem Kocyigit, Abdurrahim |
author_facet | Buyukaydin, Banu Guler, Eray Metin Karaaslan, Tahsin Olgac, Atilla Zorlu, Mehmet Kiskac, Muharrem Kocyigit, Abdurrahim |
author_sort | Buyukaydin, Banu |
collection | PubMed |
description | BACKGROUND: Diabetic polyneuropathy is a very common complication of diabetes. Numerous studies are available in terms of pathogenesis. But examination methods with low reliability are still not standardized and generally time consuming. High-sensitive, easy-to-access methods are expected. Biochemical markers are one of the subjects of research. We aimed to discover a potential biomarker that can be used for this purpose in patients with diabetes who have not yet developed symptoms of neuropathy. AIM: To determine the place and availability of visfatin and thiol-disulfide homeostasis in this disorder. METHODS: A total of 392 patients with type 2 diabetes mellitus were included in the study. The polyneuropathy clinical signs were evaluated with the Subjective Peripheral Neuropathy Screen Questionnaire and Michigan Neuropathy Screening Instrument questionnaire and examination. The biochemical parameters, oxidative stress markers, visfatin, and thiol-disulfide homeostasis were analyzed and correlated with each other and clinical signs. RESULTS: Subjective Peripheral Neuropathy Screen Questionnaire and Michigan Neuropathy Screening Instrument questionnaire with examination scores were correlated with each other and diabetes duration (P < 0.005). Neuropathy related symptoms were present in 20.7% of the patients, but neuropathy related findings were observed in 43.9% of the patients. Serum glucose, glycated hemoglobin, and visfatin were positively correlated with each other. Also, these parameters were positively correlated with the total oxidative stress index. Total and native thiol was positively correlated with total antioxidant status and negatively with oxidant status. Inversely thiol-disulfide positively correlated with higher glucose and oxidant status and negatively with total antioxidant status (P < 0.005). There was no correlation between visfatin and thiol-disulphide (P = 0.092, r = 0.086). However, a significant negative correlation was observed between visfatin and total with native thiol (P < 0.005, r = -0.338), (P < 0.005, r = -0.448). CONCLUSION: Diagnosis of neuropathy is one of the issues studied in patients with diabetes. Visfatin and thiol-disulfide balance were analyzed for the first time in this study with inspiring results. |
format | Online Article Text |
id | pubmed-7415233 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-74152332020-08-24 Relationship between diabetic polyneuropathy, serum visfatin, and oxidative stress biomarkers Buyukaydin, Banu Guler, Eray Metin Karaaslan, Tahsin Olgac, Atilla Zorlu, Mehmet Kiskac, Muharrem Kocyigit, Abdurrahim World J Diabetes Observational Study BACKGROUND: Diabetic polyneuropathy is a very common complication of diabetes. Numerous studies are available in terms of pathogenesis. But examination methods with low reliability are still not standardized and generally time consuming. High-sensitive, easy-to-access methods are expected. Biochemical markers are one of the subjects of research. We aimed to discover a potential biomarker that can be used for this purpose in patients with diabetes who have not yet developed symptoms of neuropathy. AIM: To determine the place and availability of visfatin and thiol-disulfide homeostasis in this disorder. METHODS: A total of 392 patients with type 2 diabetes mellitus were included in the study. The polyneuropathy clinical signs were evaluated with the Subjective Peripheral Neuropathy Screen Questionnaire and Michigan Neuropathy Screening Instrument questionnaire and examination. The biochemical parameters, oxidative stress markers, visfatin, and thiol-disulfide homeostasis were analyzed and correlated with each other and clinical signs. RESULTS: Subjective Peripheral Neuropathy Screen Questionnaire and Michigan Neuropathy Screening Instrument questionnaire with examination scores were correlated with each other and diabetes duration (P < 0.005). Neuropathy related symptoms were present in 20.7% of the patients, but neuropathy related findings were observed in 43.9% of the patients. Serum glucose, glycated hemoglobin, and visfatin were positively correlated with each other. Also, these parameters were positively correlated with the total oxidative stress index. Total and native thiol was positively correlated with total antioxidant status and negatively with oxidant status. Inversely thiol-disulfide positively correlated with higher glucose and oxidant status and negatively with total antioxidant status (P < 0.005). There was no correlation between visfatin and thiol-disulphide (P = 0.092, r = 0.086). However, a significant negative correlation was observed between visfatin and total with native thiol (P < 0.005, r = -0.338), (P < 0.005, r = -0.448). CONCLUSION: Diagnosis of neuropathy is one of the issues studied in patients with diabetes. Visfatin and thiol-disulfide balance were analyzed for the first time in this study with inspiring results. Baishideng Publishing Group Inc 2020-07-15 2020-07-15 /pmc/articles/PMC7415233/ /pubmed/32843933 http://dx.doi.org/10.4239/wjd.v11.i7.309 Text en ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Observational Study Buyukaydin, Banu Guler, Eray Metin Karaaslan, Tahsin Olgac, Atilla Zorlu, Mehmet Kiskac, Muharrem Kocyigit, Abdurrahim Relationship between diabetic polyneuropathy, serum visfatin, and oxidative stress biomarkers |
title | Relationship between diabetic polyneuropathy, serum visfatin, and oxidative stress biomarkers |
title_full | Relationship between diabetic polyneuropathy, serum visfatin, and oxidative stress biomarkers |
title_fullStr | Relationship between diabetic polyneuropathy, serum visfatin, and oxidative stress biomarkers |
title_full_unstemmed | Relationship between diabetic polyneuropathy, serum visfatin, and oxidative stress biomarkers |
title_short | Relationship between diabetic polyneuropathy, serum visfatin, and oxidative stress biomarkers |
title_sort | relationship between diabetic polyneuropathy, serum visfatin, and oxidative stress biomarkers |
topic | Observational Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415233/ https://www.ncbi.nlm.nih.gov/pubmed/32843933 http://dx.doi.org/10.4239/wjd.v11.i7.309 |
work_keys_str_mv | AT buyukaydinbanu relationshipbetweendiabeticpolyneuropathyserumvisfatinandoxidativestressbiomarkers AT gulereraymetin relationshipbetweendiabeticpolyneuropathyserumvisfatinandoxidativestressbiomarkers AT karaaslantahsin relationshipbetweendiabeticpolyneuropathyserumvisfatinandoxidativestressbiomarkers AT olgacatilla relationshipbetweendiabeticpolyneuropathyserumvisfatinandoxidativestressbiomarkers AT zorlumehmet relationshipbetweendiabeticpolyneuropathyserumvisfatinandoxidativestressbiomarkers AT kiskacmuharrem relationshipbetweendiabeticpolyneuropathyserumvisfatinandoxidativestressbiomarkers AT kocyigitabdurrahim relationshipbetweendiabeticpolyneuropathyserumvisfatinandoxidativestressbiomarkers |